NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+2.46%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.43B
AUM Growth
+$1.43B
(-26%)
Cap. Flow
-$572M
Cap. Flow
% of AUM
-40.04%
Top 10 Holdings %
Top 10 Hldgs %
64.34%
Holding
48
New
3
Increased
2
Reduced
2
Closed
4
Top Buys
| 1 |
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
|
$87.2M |
| 2 |
Trevi Therapeutics
TRVI
|
$33.2M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$2.91M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$1.8M |
| 5 |
RGLS
Regulus Therapeutics
RGLS
|
$1.42M |
Top Sells
| 1 |
Elastic
ESTC
|
$444M |
| 2 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$109M |
| 3 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$70.7M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$31.4M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$30.8M |
Sector Composition
| 1 | Healthcare | 91.04% |
| 2 | Technology | 5.28% |
| 3 | Industrials | 1.15% |
